Back to results
US 2020/0046779 A1Published application
Anti-inflammatory exosomes from inflamed cells or tissues
AssigneeVbc Holdings LLC
InventorsKayvan NIAZI, Francesco CURCIO
Life of this patent
Estimating the term…
Abstract
The invention provides anti-inflammatory exosomes that, when administered locally or systemically to a subject diagnosed with an inflammatory disease or disorder, will downregulate the inflammatory process in the subject.
Claims28
A method of producing anti-inflammatory exosomes capable of inhibiting inflammation in a subject diagnosed with an inflammatory disease or disorder, the exosomes produced by a process comprising:
- a) culturing animal cells or tissues in a suitable culture medium, for a time period sufficient for the culture medium to accumulate a useful concentration of anti-inflammatory exosomes, wherein the culture medium comprises an activating composition,
- (b) collecting the culture medium of (a), and
- (c) isolating anti-inflammatory exosomes from the culture medium collected in (b);
- wherein the activating composition comprises at least one of:
- (i) fluid extracted from inflamed tissue or other anatomical structure of a mammal diagnosed with the inflammatory disease or disorder,
- (ii) blood, plasma or serum from a subject diagnosed with the inflammatory disease or disorder,
- (iii) the fluid of (i) or (ii) further comprising at least one cytokine at a concentration sufficient to enhance the effectiveness of the activating composition comprising (i) or (ii),
- (iv) one or more cytokines at a concentration sufficient to induce the animal cells to secrete anti-inflammatory exosomes capable of inhibiting inflammation in a subject, and the activating composition excludes the fluid of (i) and/or the blood, plasma or serum of (ii).
5 more elements
Dependencies are inferred from the claim text.